The current study
depression
POSITIVE
In this parallel randomized controlled trial 100 families were randomly allocated to either the experimental group (EG), who received GuG-Auf, or the control group (CG), who received no intervention. We conducted assessments at 6- (T2) 9- (T3) and 15- (T4) months after baseline (T1). A previous manuscript reported effects in the short-term (T2) using data from the oldest child from each family [The analyses reported here are based on apriori hypotheses generated prior to commencing the trial and independent of the analyses of the T1-T2 data [Positive effects of the FGCB on self-reported symptoms of depression and externalizing symptoms (proxies for depression risk) only emerged 12-months after baseline [Our Due to heterogenous previous findings [Finally, in line with previous studies [